Sarah M. Fortune mostly deals with Mycobacterium tuberculosis, Cell biology, Tuberculosis, Genetics and Microbiology. The concepts of her Mycobacterium tuberculosis study are interwoven with issues in Macrophage, Siderophore, Bacteria and Function. Her Cell biology research incorporates elements of Proteases, Downregulation and upregulation, Single-cell analysis, Interferon-stimulated gene and Lung injury.
Her Tuberculosis research is multidisciplinary, incorporating elements of Mutation rate, Whole genome sequencing and Virology. Her work on RNA and Gene as part of general Genetics study is frequently linked to Computer hardware, Massively parallel and Throughput, bridging the gap between disciplines. She interconnects Immunology and Isoniazid in the investigation of issues within Latent tuberculosis.
Sarah M. Fortune spends much of her time researching Mycobacterium tuberculosis, Tuberculosis, Genetics, Immunology and Microbiology. Her Mycobacterium tuberculosis study combines topics from a wide range of disciplines, such as Virology, Immune system, Disease, Mutation rate and Granuloma. The Tuberculosis study which covers Antibiotics that intersects with Drug tolerance.
Her Gene, Whole genome sequencing, Locus and Genomics study in the realm of Genetics interacts with subjects such as Bacterial genetics. Her Microbiology research incorporates themes from Mutagenesis, Bacteria and Cell biology. Her work carried out in the field of Cell biology brings together such families of science as Macrophage and Mycobacterium smegmatis.
Sarah M. Fortune mainly focuses on Mycobacterium tuberculosis, Tuberculosis, Immune system, Immunology and Cell biology. The various areas that Sarah M. Fortune examines in her Mycobacterium tuberculosis study include Antigen, Drug resistance, Microbiology, Antibody and Computational biology. Her research integrates issues of Genetics and Antibiotic resistance in her study of Tuberculosis.
Her biological study spans a wide range of topics, including Tuberculin and Disease. Her Cell biology research is multidisciplinary, incorporating elements of Interferon, Downregulation and upregulation, Cell culture and Transcription factor. Her study in Downregulation and upregulation is interdisciplinary in nature, drawing from both Proteases, TMPRSS2, Single-cell analysis, Interferon-stimulated gene and Lung injury.
Her scientific interests lie mostly in Mycobacterium tuberculosis, Antibiotics, Cell culture, Tuberculosis and Microbiology. The concepts of her Mycobacterium tuberculosis study are interwoven with issues in Rifampicin, Antigen, Rifamycins, Antibody and Drug resistance. Her research in the fields of Antibiotic resistance and Antibiotic therapy overlaps with other disciplines such as Extramural.
Sarah M. Fortune combines subjects such as TMPRSS2, Interferon, Proteases, Downregulation and upregulation and Single-cell analysis with her study of Cell culture. As part of her studies on Tuberculosis, she often connects relevant subjects like Chemoprophylaxis. Her Microbiology research includes elements of RNA, Gene, Secretion and Gene expression profiling.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano.
Definitions and guidelines for research on antibiotic persistence
Naomi N.Q. Balaban;Sophie Helaine;Kim Lewis;Martin Ackermann;Martin Ackermann.
Nature Reviews Microbiology (2019)
Mutually dependent secretion of proteins required for mycobacterial virulence
S. M. Fortune;A. Jaeger;D. A. Sarracino;M. R. Chase.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection
Christopher B Ford;Philana Ling Lin;Michael R Chase;Rupal R Shah.
Nature Genetics (2011)
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
Philana Ling Lin;Christopher B Ford;Christopher B Ford;M Teresa Coleman;Amy J Myers.
Nature Medicine (2014)
Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput
Todd M Gierahn;Marc H Wadsworth;Marc H Wadsworth;Marc H Wadsworth;Travis K Hughes;Travis K Hughes;Travis K Hughes;Bryan D Bryson;Bryan D Bryson.
Nature Methods (2017)
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
Christopher B Ford;Rupal R Shah;Midori Kato Maeda;Sebastien Gagneux;Sebastien Gagneux.
Nature Genetics (2013)
A Functional Role for Antibodies in Tuberculosis
Lenette L. Lu;Lenette L. Lu;Amy W. Chung;Amy W. Chung;Tracy R. Rosebrock;Musie Ghebremichael.
Beyond binding: antibody effector functions in infectious diseases.
Lenette L. Lu;Todd J. Suscovich;Sarah M. Fortune;Galit Alter.
Nature Reviews Immunology (2018)
Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair
Maziar Divangahi;Minjian Chen;Huixian Gan;Danielle Desjardins.
Nature Immunology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: